NASDAQ:STAA STAAR Surgical Q3 2026 Earnings Date & Estimates $21.67 -0.71 (-3.17%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$21.50 -0.17 (-0.79%) As of 10/9/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. STAAR Surgical is expected to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market Closes Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from STAAR Surgical in Q3 2026STAAR Surgical is expected to post earnings of $0.0503 per share on revenue of $78.74 million. STAAR Surgical last reported on August 12, 2026, posting $0.39 per share and beating the $0.2214 consensus estimate. STAAR Surgical has beaten the consensus EPS estimate in 3 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.0503Expected Revenue$78.74 millionRecent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.39 (Beat by +$0.1686)Last Quarter Revenue$93.54 millionEPS Beat Rate3 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report STAAR Surgical Q3 2026 Earnings FAQ When does STAAR Surgical report Q3 2026 earnings? STAAR Surgical (NASDAQ:STAA) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is STAAR Surgical's Q3 2026 earnings call? STAAR Surgical's Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for STAAR Surgical? Analysts expect STAAR Surgical to post earnings of $0.0503 per share for Q3 2026. How much revenue is STAAR Surgical expected to report? The consensus revenue estimate for STAAR Surgical is $78.74 million for Q3 2026. STAAR Surgical Earnings HeadlinesWall Street Zen Upgrades STAAR Surgical (NASDAQ:STAA) to BuyOctober 10 at 1:31 AM | americanbankingnews.comWinners And Losers Of Q2: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Medical Devices & Supplies - Specialty StocksOctober 8 at 8:20 PM | finance.yahoo.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.October 11 at 1:00 AM | Banyan Hill Publishing (Ad)STAAR Surgical Names Andrew Pilon as Vice President of Business DevelopmentOctober 8 at 4:00 PM | businesswire.comSTAAR Surgical: A Recovery Story Priced As GrowthOctober 1, 2026 | seekingalpha.comSTAAR Surgical (NASDAQ:STAA) Stock Rating Upgraded by Stifel NicolausOctober 1, 2026 | americanbankingnews.comSee More STAAR Surgical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like STAAR Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on STAAR Surgical and other key companies, straight to your email. Email Address About STAAR SurgicalSTAAR Surgical (NASDAQ:STAA) is a medical device company focused on ophthalmic surgery and vision correction. The company develops, manufactures and markets implantable lenses and related products designed to reduce or eliminate dependence on glasses or contact lenses. Its principal product line is the EVO Visian Implantable Collamer Lens (ICL), a lens implanted inside the eye to correct myopia, with or without astigmatism. Unlike procedures that remove corneal tissue, ICL surgery preserves the eye’s natural lens and is designed to be removable. STAAR Surgical also offers other ophthalmic lenses and surgical products for refractive and cataract-related procedures, depending on the market. Founded in 1982, STAAR Surgical serves ophthalmic surgeons and patients internationally through direct operations and distribution partners. Its products are marketed across the United States and numerous international markets, including countries in Europe and the Asia-Pacific region. The company is headquartered in Lake Forest, California, and its common stock trades on the Nasdaq under the symbol STAA.View STAAR Surgical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
